Indrayani Biotech Launches Rights Issue Worth ₹487.88 Cr

Indrayani Biotech Limited has announced a Rights Issue of up to 3,25,25,897 partly paid-up Equity Shares at an issue price of ₹15 per share, aggregating up to ₹4878.88 Lakhs (₹487.88 Crores). The issue is on a rights basis to eligible equity shareholders in the ratio of 5 shares for every 7 fully paid-up shares held as of the record date, April 28, 2026. The issue price includes a premium of ₹5 per share. The company was originally incorporated in 1992 and later converted to a public limited company. The Rights Issue Committee has approved the Letter of Offer, which details the payment structure with ₹3.75 payable on application and ₹11.25 on subsequent calls. Investors are advised to review the risk factors before making investment decisions.